Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Replimune Group, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +29 vs. Q3 2022
- Shares held
- 48.2M
- +7.43M (+18.2%) vs. Q3 2022
- Total value
- $1.31B
- +$606.5M (+86.2%) vs. Q3 2022
- New holders
- 33
- 62 more added
- Sold out
- 4
- 24 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 197,722 | $5.38M | 0.00% | +61,447+45.1% | Added |
| Resolute Capital Asset Partners LLC | 210,000 | $5.71M | 5.10% | +210,000 | New |
| Ameriprise Financial Inc | 214,679 | $5.84M | 0.00% | −1,990−0.9% | Reduced |
| Integral Health Asset Management, LLC | 220,000 | $5.98M | 1.35% | +20,000+10.0% | Added |
| Charles Schwab Investment Management Inc | 259,577 | $7.06M | 0.00% | +7,337+2.9% | Added |
| Ensign Peak Advisors, Inc | 270,007 | $7.34M | 0.02% | +215,840+398.5% | Added |
| Millennium Management LLC | 275,496 | $7.49M | 0.01% | +137,383+99.5% | Added |
| Wellington Management Group LLP | 284,305 | $7.73M | 0.00% | +257,842+974.3% | Added |
| Northern Trust Corp | 405,935 | $11.0M | 0.00% | +21,143+5.5% | Added |
| Amundi | 421,442 | $11.1M | 0.01% | +56,281+15.4% | Added |
| Schroder Investment Management Group | 424,855 | $11.6M | 0.02% | +79,356+23.0% | Added |
| Point72 Asset Management, L.P. | 437,900 | $11.9M | 0.04% | +368,075+527.1% | Added |
| Citadel Advisors LLC | 555,976 | $15.1M | 0.02% | −90,047−13.9% | Reduced |
| Victory Capital Management Inc | 576,487 | $15.7M | 0.02% | +576,487 | New |
| Morgan Stanley | 614,156 | $16.7M | 0.00% | +55,726+10.0% | Added |
| Braidwell LP | 662,349 | $18.0M | 0.60% | +662,349 | New |
| Candriam Luxembourg S.C.A. | 662,922 | $18.0M | 0.12% | +53,350+8.8% | Added |
| Geode Capital Management, LLC | 699,145 | $19.0M | 0.00% | +14,132+2.1% | Added |
| Artal Group S.A. | 700,000 | $19.0M | 1.10% | −200,000−22.2% | Reduced |
| Dimensional Fund Advisors LP | 725,888 | $19.7M | 0.01% | +78,532+12.1% | Added |
| Frazier Life Sciences Management, L.P. | 931,560 | $25.3M | 1.58% | +125,293+15.5% | Added |
| Emerald Mutual Fund Advisers Trust | 965,938 | $26.3M | 1.63% | 00.0% | Unchanged |
| Camber Capital Management LP | 1,000,000 | $27.2M | 0.95% | +1,000,000 | New |
| Emerald Advisers, LLC | 1,186,041 | $32.3M | 1.56% | +49,455+4.4% | Added |
| T. Rowe Price Investment Management, Inc. | 1,236,717 | $33.6M | 0.03% | +9,847+0.8% | Added |
| FMR LLC | 1,380,434 | $37.5M | 0.00% | +287,681+26.3% | Added |
| State Street Corp | 1,479,544 | $40.2M | 0.00% | +27,769+1.9% | Added |
| BVF Inc | 1,522,629 | $41.4M | 1.75% | +596,100+64.3% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $57.1M | 6.87% | −1,010,000−32.5% | Reduced |
| Vanguard Group Inc | 2,242,992 | $61.0M | 0.00% | +394,825+21.4% | Added |
| BlackRock Inc. | 3,010,552 | $81.9M | 0.00% | +244,181+8.8% | Added |
| Omega Fund Management, LLC | 3,361,806 | $91.4M | 30.82% | −926,348−21.6% | Reduced |
| Baker Bros. Advisors LP | 4,578,280 | $124.5M | 0.75% | +684,437+17.6% | Added |
| Redmile Group, LLC | 4,831,709 | $131.4M | 5.38% | +1,186,400+32.5% | Added |
| Price T Rowe Associates Inc | 5,064,744 | $137.8M | 0.02% | +893,573+21.4% | Added |
| Great Point Partners LLC | 0 | $0 | 0.00% | −390,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −84,634−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,566−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,252−100.0% | Sold out |